CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 60 enrolled
Drug / intervention
Drug: Bupivacaine 0.375% 20 mL +1 moredrug
Likely dose
Drug: Bupivacaine 0.375% 20 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04259645
NCT04259645Phase 4Completed

Volume Versus Concentration: A Prospective, Double Blind, Parallel Study to Compare the Clinical Effectiveness of Single Shot Quadratus Lumborum Block Using Either a High Volume/Low Concentration or Low Volume/High Concentration Injectate for Total Hip Arthroplasty.

Anna Uskova·interventional·Posted Feb 6, 2020·Updated Jul 10, 2024

In Brief

A Phase 4 clinical trial evaluating Drug: Bupivacaine 0.375% 20 mL and Drug: Bupivacaine 0.375% diluted to 0.1875% for Acute Pain. Completed, enrolled 60 participants across 2 sites.

Detailed Summary

There is Controversy about what is more critical volume or concentration to achieve an optimum analgesic treatment with quadratus lumborum block. From the experiences of the authors, the regular dose of 20 ml of Bupivacaine at 0.375% concentration could not be enough in some cases to produce an optimum analgesic treatment, especially in hip arthroplasties. What is proposed in this study is to evaluate whether the volume injected in the quadratus lumborum block is more important than the concentration of the local anesthetic in terms of control of pain during the next 24 hours after surgery and opioid consumption.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Pain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedFeb 6, 2020
Enrollment StartApr 1, 2021
Primary CompletionJan 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.4 years ago

Interventions

Drug: Bupivacaine 0.375% 20 mLdrug

20 mL 0.375% Bupivacaine

Drug: Bupivacaine 0.375% diluted to 0.1875%drug

Each block of 0.375% Bupivacaine x 20 ml mixed (diluted) with Normal Saline Solution 20 mL (total 40 mL)